It’s no surprise that virtual care has become mainstream—we have officially entered the era of the “virtual front door”. But where are U.S. health insurance providers investing and how do they expect to realize value for their members, their organization, and their clients?
The most comprehensive survey of health plans to date reveals why and where health insurance providers are growing their virtual care offerings, what they expect to gain from their investments, and how health payers are prioritizing virtual care in the near term. During this webinar, you’ll also also hear about “Bright Spots” where virtual care provides value across lines of business—ASO, Medicaid Managed Care and Medicare—and “Lessons Learned” along the way.
During this presentation you’ll learn about:
Senior Vice President of Product & Strategy
Dan Trencher oversees the development and execution of new growth opportunities and products for Teladoc Health, leading business initiatives that deliver compelling user experiences and transforms how people access quality care. He ensures that Teladoc Health delivers innovative commercial products, leading long-term road mapping, market analysis, product development & management, and project execution.
Mr. Trencher brings a breadth of experience in the healthcare industry, including hands-on product and operational expertise from a wide array of healthcare customer segments. Prior to Teladoc Health, Mr. Trencher held leadership roles at WellPoint (now Anthem Inc.) and WellChoice, Inc. developing and managing growth initiatives across the healthcare value chain, ranging from providers to disease management and wellness programs to health information technology.
Mr. Trencher holds a bachelor’s degree in economics from the University of Pennsylvania, and a Master of Business Administration degree from the University of Chicago.
Craig F. Burns, PhD, MS
Vice President of Research, The Center for Policy & Research
Craig is currently the Vice President of Research for the health insurance industry trade association, America’s Health Insurance Plans (AHIP). His research, since joining AHIP’s Center for Policy and Research in 2014, is focused mainly on the economic impacts of prescription medications on the healthcare system. He has extensive experience in conducting economic modeling studies, insurance claims database analyses; as well as, survey-based research projects across a variety of healthcare topics.
Craig began his career in 1996 as a Regulatory Affairs Associate for British Biotech. In 1999, he joined MedImmune, as a Project Manager where he coordinated the research and development efforts of multiple cross-disciplinary teams tasked with developing monoclonal antibodies in the autoimmune and oncology areas. In 2003, he joined Sanofi’s research and development organization as a Project Director and led multiple, international, cross-disciplinary teams in developing drugs and biologics in the oncology therapeutic area. Dr. Burns has acquired considerable experience and expertise in all aspects of drug development and approval in Europe, the United States, and Japan.
Craig’s undergraduate degree in Chemistry was awarded by The University of Tulsa; he holds a Master of Science degree in Toxicology from Oklahoma State University; and a PhD in Health Economics and Health Services Research from The University of Oklahoma’s College of Pharmacy.